logologo

close

COPYRIGHT 2020 POSVAX CO. LTD. ALL RIGHTS RESERVED.

r&d

Prophylactic Vaccines

Nonavalent HPV Vaccine

kids

Nearly 100 % of cervical cancer is caused by infection with human papillomavirus (HPV). The HPV also causes genital warts, head & neck cancer and anal cancer etc. HPV vaccines have strong significance in that they are the first prophylactic cancer vaccines of human beings.

Cancer types and patients due to HPV infection in
  • Cervical cancer
  • Anal cancer
  • Head-neck cancer
  • Vaginal cancer
  • 570,000
  • 38,000
  • 35,000
  • 33,500

Source) De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site,
country and HPV type, International Journal
of Cancer. 2017;141(4):664-670. doi:10.1002/ijc.30716

Nonavalent HPV Vaccines Highlights

POSVAX
Nonavalent HPV
VACCINES

FEATURES
  • Registered patent
    worldwide (25 countries)
  • Excellent immunogenicity and
    high-efficiency production
  • Vaccine localization and
    expected export
STATE OF
DEVELOPMENT
  • Non-clinical trial in 2019
  • IND approval in 2021
  • Plan to apply for global
    phase II study in 2024
EFFICACY
  • Prevent a variety of
    cancers including cervical
    cancers, head & neck
    cancers, anal cancers and
    vaginal cancers
  • Prevent genital warts
FUTURE
MARKET
  • Steady increasing number
    of countries starting national
    HPV Nonavalent vaccine programs
  • Increasing male vaccine
    acceptance
  • Entry to global premium
    vaccine market